Navigation Links
Definiens to Introduce New Generation of Products for Tissue-based Biomarker Research at the International Definiens Symposium
Date:9/20/2011

MUNICH, Sept. 20, 2011 /PRNewswire/ -- Definiens, the leading Health Image Intelligence™ company, announces that it will release a new generation of products at the International Definiens Symposium at the Moffitt Cancer Center in Tampa, FL on October 17–18. The annual symposium is the premier forum for Definiens users and developers from around the world to present the latest applications, research and workflows in life science image and data analysis. One focus of this year's symposium will be tissue-based biomarker research and image analysis in clinical trials. The high-caliber program will include a speaker panel with key opinion leaders from industry and academia.

Definiens Tissue Studio® software has already been established as an industry standard. Building on the company's vast background in biomedical image analysis and biomarker research, existing products for image analysis, such as Tissue Studio, will be significantly improved, with a focus on Quantitative Digital Pathology.  In addition, a completely new component will be added to Definiens' suite of products, which will allow users to leverage the enormous value of received measurements and data. This component will closely integrate image analysis with data and image mining.

The technology will provide high accuracy in automatically identifying relevant structures of interest and specific morphology in histology, resulting in a detailed phenotypic fingerprint and biomarker expression profile on a cell-by-cell basis. The large set of descriptors can be correlated against therapy response or patient outcome with the goal to identify new types of biomarkers of predictive or prognostic value.

"It is clear that today only a small portion of the information contained in tissue biopsies is used for research or diagnosis and the interpretation is subjective," says Thomas Heydler, CEO of Definiens.  "With the statistical power of many detailed readouts from a tumor specimen combined with our new data mining capabilities, we are addressing the needs of scientists and exploring new possibilities in tissue-based biomarker development."

In recent years, Definiens has generated a large footprint over the entire bandwidth of biomedical applications, specifically in the field of Quantitative Digital Pathology and Biomarker Research, which continues to expand with the upcoming additions to the company's suite of products. For more information about the upcoming product launch, please visit quantitative-digital-pathology.definiens.com.

For more information on the upcoming International Definiens Symposium, please visit www.definiens.com/community/symposium.html.

About Definiens

Definiens is a leading Health Image Intelligence™ company that develops software solutions for biomedical image analysis, data mining and clinical decision support. The company's software analyzes images from cell-based assays, whole tissue slides and full body scans and allows users to correlate this information with data derived from other sources, supporting better decisions in research, diagnostics and therapy. By automating analysis workflows and generating new knowledge, Definiens provides pharmaceutical and biotechnology companies, research institutions, clinical service organizations and medical professionals with deeper insights, faster results and better decision support. Harnessing the power of image intelligence, Definiens supports personalized medicine and aims to significantly improve the quality of patients' lives.

Definiens is headquartered in Munich, Germany, and has offices throughout the United States. Further information is available at www.definiens.com.

Press Contacts:
Definiens, Inc.
Dr. Martin Baatz
Vice President Marketing
mbaatz@definiens.com

Ricochet PR
Mia Scott
mscott@ricochetpr.com
212.679.3300 ext. 120


'/>"/>
SOURCE Definiens
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Metamark Genetics Partners with Definiens on Tissue-Based Cancer Diagnostics
2. Advanced Cell Diagnostics and Definiens Partner to Develop Tool for Quantitative Biomarker Analysis
3. Mindray Introduces DP-50 Portable Ultrasound System in the U.S.
4. Bausch + Lomb and Technolas™ Perfect Vision Introduce VICTUS™ Femtosecond Laser Platform at 2011 ESCRS Meeting
5. Lewis County Introduces Prescription Discount Card to Help Alleviate High Costs
6. NeurOptics Introduces First Hand-held Variable Light Condition Pupillometer to Optimize Outcomes for Refractive Surgery and Premium Intraocular Lens Candidates
7. Bourns Introduces Two New Industrial-Grade Panel Control Models
8. Verathon® Introduces the Heartscape™ 3D ECG System with 80-Lead Vest in Europe; Technology Provides More Complete Data to Help Diagnose Acute Myocardial Infarction (MI)
9. Otero County Introduces Prescription Discount Card to Help Alleviate High Costs
10. UBM Canon Introduces a Compelling New Virtual Conference Focused on Track & Trace Solutions for the Pharma Sector
11. YASOO Health Introduces IronUp™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... , Jan. 20, 2017 ResMed (NYSE: RMD ... ( Winter Haven, Florida ) today announced they have ... BMC and 3B will be permitted to sell their existing products ... a one-time settlement payment to 3B to close the ... not include an admission of liability or wrongdoing by any party. ...
(Date:1/21/2017)... Research and Markets has announced the addition ... Technology, Route Of Administration, End User - Forecast to 2025" ... ... at a CAGR of around 7.8% over the next decade to ... report analyzes the global markets for Advanced Drug Delivery across all ...
(Date:1/20/2017)... , Jan. 20, 2017  Ethicon Endo-Surgery, ... Megadyne Medical Products, Inc., a privately held ... markets electrosurgical tools used in operating rooms ... of Ethicon,s* advanced energy devices with Megadyne,s ... major step forward in Ethicon,s goal to ...
Breaking Medicine Technology:
(Date:1/23/2017)... NY (PRWEB) , ... January 23, 2017 , ... ... today that John J. Nelson, a senior accountant at the Firm, will participate in ... Make-A-Wish® Hudson Valley. Over 200 runners will race up 1,576 steps, a vertical distance ...
(Date:1/23/2017)... ... 23, 2017 , ... Wooden and plastic balance boards have been around since at least the ... Board is the first and only balance board to use a patent-pending design featuring ... at the same time as well as skill-level adjustable for all ages and abilities. ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... Crystallization in Process Chemistry by Applying Simple PAT Tools . , ... to isolate and purify the desired product. Chemists now spend more time ...
(Date:1/23/2017)... , ... January 23, 2017 ... ... Foundation (OREF), in partnership with the American Society of Anesthesiologists® (ASA®), the ... (APSF), the American Academy of Orthopaedic Surgeons (AAOS) and the Cigna Foundation, ...
(Date:1/23/2017)... ... ... “Life Under Blankets”: an entrancing story about one woman's travels through the wilderness ... of published author, Kimberly Mitchell, who earned her bachelor’s degree in English education at ... master’s degree in education in the field of curriculum and instruction. Kimberly’s passion for ...
Breaking Medicine News(10 mins):